FDA Recalls 7-Keto DHEA Capsules Due to Expired Ingredient
KRS Global Biotechnology is recalling 7-Keto DHEA 100 mg capsules because the product's expiration date exceeds the expiration date of at least one ingredient.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which the rubric associates with moderate severity, specifically involving labeling errors and low-risk contamination without reported injuries.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a recall for 7-Ketodehydroepiandrosterone (7-Keto DHEA) 100 mg capsules manufactured by KRS Global Biotechnology, Inc. The recall is limited to Lot 08012017@35, which has a Beyond Use Date (BUD) of January 28, 2018. The product is a prescription-only medication packaged in bottles of 90 capsules.
The recall was initiated due to a labeling and quality control issue where the Beyond Use Date (BUD) of the final product exceeds the expiration date of at least one ingredient used in its manufacture. This discrepancy indicates that the product may contain ingredients that were past their expiration date at the time the final product was labeled with its expiration date.
The affected capsules were distributed nationwide in the United States, as well as in Bermuda and New Zealand. Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on disposal or replacement.
The recalled product
- Product
- 7-Ketodehydroepiandrosterone (7-Keto DHEA) 100 mg Capsule, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.
- Manufacturer
- KRS Global Biotechnology, Inc
- Category
- Drug — Prescription Capsules
- Affected units
- 90
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 08012017@35 BUD: 1/28/2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 47 recalled by KRS Global Biotechnology, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 47 products in this recall →Related recalls
Same manufacturer · KRS Global Biotechnology, Inc
See all →- SevereKRS Global Biotechnology Recalls Lidocaine HCl Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereKRS Global Biotechnology Recalls Human Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereFDA Recalls Phenylephrine IV Bags Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- ModerateSermorelin and GHRP-2 Lyophilized Vials Recalled Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereKRS Global Biotechnology Recalls Phenylephrine IV Bags Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02